With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, The ligand (50.0 mg, 0.11 mmol) was added to a suspension of copper(II) halogenide (0.11 mmol) in methanol (3 ml). The mixture was stirred at r. t. for 16 h. The precipitate was then filtered off and dried in vacuo. The pure compounds were obtained by recrystallization from dichloromethane and pentane.
As the paragraph descriping shows that 7787-70-4 is playing an increasingly important role.
Reference£º
Article; Sauer, Desiree C.; Wadepohl, Hubert; Polyhedron; vol. 81; (2014); p. 180 – 187;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”